• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Device Evaluation (ODE) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 20118583
Nov 20118584
Dec 20118582
Jan 20128588
Feb 20128580
Mar 20128587
Apr 20128584
May 20128587
Jun 20128586
Jul 20128588
Aug 20128584
Sep 20128584

FY 2012 Overall: 85%

Number of ODE intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A626
Nov 2011N/A698
Dec 2011N/A594
Jan 2012N/A629
Feb 2012N/A622
Mar 2012N/A814
Apr 2012N/A739
May 2012N/A763
Jun 2012N/A727
Jul 2012N/A809
Aug 2012N/A802
Sep 2012N/A641

FY 2012 Total: 8,464

Total number of ODE intra- and inter-Office eConsults completed during the month

Fiscal Year - 2012
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2011N/A750
Nov 2011N/A831
Dec 2011N/A728
Jan 2012N/A713
Feb 2012N/A779
Mar 2012N/A939
Apr 2012N/A883
May 2012N/A878
Jun 2012N/A849
Jul 2012N/A917
Aug 2012N/A950
Sep 2012N/A761

FY 2012 Total: 9,978

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.